Effect and application of cryopreserved three-dimensional microcardiac spheroids in myocardial infarction therapy

Clin Transl Med. 2022 Jan;12(1):e721. doi: 10.1002/ctm2.721.

Soon-Jung Park^{1

2}, Hyeok Kim^{3

4}, Sunghun Lee⁵, Jongsoo Kim^{1

6}, Taek-Hee Jung^{1

2}, Seong Woo Choi⁷, Bong-Woo Park^{3

4}, Sun-Woong Kang⁸, David A Elliott⁹, Edouard G Stanley⁹, Andrew G Elefanty⁹, Kiwon Ban⁵, Hun-Jun Park^{3

4

10}, Sung-Hwan Moon^{1

2}

¹ Department of Medicine, Konkuk University School of Medicine, Seoul, Korea.
² Research Institute, T&R Biofab Co. Ltd, Siheung, Korea.
³ Department of Medical Life Science, College of Medicine, The Catholic University of Korea, Seoul, Korea.
⁴ Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
⁵ Department of Biomedical Sciences, City University of Hong Kong, Kowloon, Hong Kong SAR.
⁶ Department of Surgery, Wexner Medical Center, Ohio State University, Columbus, Ohio, USA.
⁷ Department of Physiology, Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Korea.
⁸ Research Group for Biomimetic Advanced Technology, Korea Institute of Toxicology, Daejeon, Korea.
⁹ Monash Immunology and Stem Cell Laboratories, Monash University, Clayton, Victoria, Australia.
¹⁰ Cell Death Disease Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.

No abstract available

Publication types